Joan N Kyula-Currie

5PUBLICATIONS
46CO-AUTHORS
ChemotherapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 22, 2025
Xevinapant plus Chemoradiotherapy Negatively Sculpts the Tumor-Immune Microenvironment in Head and Neck Cancer.

Charleen Chan Wah Hak, Emmanuel C Patin, Anton Patrikeev

|Jul 08, 2025
The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse models.

Joan Kyula-Currie, Victoria Roulstone, James Wright

|Dec 12, 2024
CXCL12-Targeted Immunomodulatory Gene Therapy Reduces Radiation-Induced Fibrosis in Healthy Tissues.

James T Paget, Joseph A Ward, Andrew R McKean

|Mar 20, 2019
PD-1 Blockade Following Isolated Limb Perfusion with Vaccinia Virus Prevents Local and Distant Relapse of Soft-tissue Sarcoma.

Henry G Smith, David Mansfield, Victoria Roulstone

|Jan 26, 2018
Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues.

Aadil A Khan, James T Paget, Martin McLaughlin

Pageof 1